Japanese Healthtech Stock News

As global markets navigate geopolitical uncertainties and inflationary pressures, investors are increasingly turning their attention to stable income-generating opportunities. In this environment, dividend stocks in Asia offer a compelling option for those seeking consistent returns, as they combine the potential for capital appreciation with regular income streams.

Takeda Pharmaceutical (TSE:4502) has secured exclusive U.S. development and commercialization rights to rusfertide. The change follows Protagonist Therapeutics' decision to opt out of the collaboration. Rusfertide is currently under FDA Priority Review in the U.S. For investors watching Takeda, this move centers attention on its rare disease pipeline and its broader focus on specialty medicines. By taking full U.S. control of rusfertide, Takeda aligns the asset with its existing...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Investors may be wondering whether Terumo's current share price still reflects its true worth, or if the recent weakness has opened up a potential opportunity. The stock last closed at ¥2,055.5, with returns of a 4.2% decline over 7 days, a 3.6% decline over 30 days, a 9.1% decline year to date, and a 24.3% decline over the past year, set against modest gains over 3 and 5 years of 3.7% and 4.6% respectively. Recent coverage has focused on Terumo's role within the medical equipment space and...

As you might know, Keyence Corporation ( TSE:6861 ) just kicked off its latest yearly results with some very strong...

If you are wondering whether Daiichi Sankyo Company is priced attractively right now, it helps to separate short term share price swings from a clearer view of underlying value. The stock last closed at ¥2,650.5, with a 9.1% decline over 7 days, a 9.5% decline over 30 days, a 24.9% decline year to date and a 22.6% decline over the past year. These moves may have changed how the market views its risk and reward profile. Recent news coverage has focused on Daiichi Sankyo Company in the context...

The full-year results for Kikkoman Corporation ( TSE:2801 ) were released last week, making it a good time to revisit...

As you might know, Chugai Pharmaceutical Co., Ltd. ( TSE:4519 ) just kicked off its latest first-quarter results with...

If you are wondering whether NTT’s current share price offers fair value or not, the key is to separate the recent noise from what the numbers actually say about the business. The stock last closed at ¥151.1, with returns of 4.9% over 1 year and 61.0% over 5 years. Over the past 30 days the share price shows a 5.0% decline, and the year-to-date return sits at a 5.3% decline. Recent coverage has focused on NTT’s position as a major telecom player in Japan and how it fits into ongoing sector...

FUJIFILM Holdings Corporation announced that it has begun offsetting 100% of its group companies’ electricity usage in the United States and Canada through renewable energy certificates tied to a Texas-based solar project, under a Virtual Power Purchase Agreement with Geronimo Power. This arrangement supports generation of 300,000 MWh annually, corresponding to about 90,000 metric tons of CO2 emissions per year, covering roughly 10% of the Fujifilm Group’s global annual CO2 emissions as of...

In April 2026, Trend Micro announced that its consumer business would operate under the new TrendLife brand and introduced Kaleida, an AI-powered family-focused cybersecurity companion designed to protect digital lives in the AI era. This shift highlights how Trend Micro is repositioning its consumer offering around AI-driven privacy and safety concerns, especially as families adopt AI tools more widely. Next, we’ll examine how the TrendLife rebrand and Kaleida launch may influence Trend...

On April 17, 2026, Marubeni Corporation’s board approved proposals to shift to a Company with Three Statutory Committees, adjust its business purposes, and implement leadership changes including a new CFO following Takayuki Furuya’s medical leave and the planned retirement of outside director Yuri Okina. These moves mark a meaningful governance reshaping, concentrating oversight in dedicated committees while preserving continuity in the finance function under incoming CFO Chijo Tajima. Next,...

Money Forward, Inc. reported past first-quarter 2026 results with sales of ¥14,670.08 million and net income of ¥1,828.88 million, a clear turnaround from a net loss a year earlier. On the same day, the board met to consider introducing a shareholder benefit program, while full-year guidance was essentially reaffirmed, with only a clarification to how SaaS annual recurring revenue is categorized. We’ll now examine how this sharp swing to profitability and the planned shareholder benefit...

UK restructuring move puts Franco Manca under the spotlight TORIDOLL Holdings (TSE:3397) has called a board meeting for April 16, 2026, to consider starting a UK restructuring process for Franco Manca 2 UK Limited, the operator of its Fulham group pizza chain. See our latest analysis for TORIDOLL Holdings. The restructuring news comes as TORIDOLL Holdings trades at ¥4,108, with a 30 day share price return decline of 5.84% and a 1 year total shareholder return decline of 4.33%. However, the 5...

If you are wondering whether Metaplanet is attractively priced or already reflecting high expectations, the current share price raises some important questions about value and risk. At a last close of ¥328, the stock has seen a 3.2% decline over the past week, a 7.9% gain over the past month, a 29.9% year to date decline, and a 4.7% decline over the past year. Its 3 year return is very large and its 5 year return is almost 5x. Recent coverage around Metaplanet has focused on its role as a...

Advantest (TSE:6857) closed out FY 2026 with fourth quarter revenue of ¥328.1 billion and basic EPS of ¥174.81, backed by trailing twelve month revenue of ¥1.1 trillion and EPS of ¥515.15 that sits alongside 132.9% earnings growth and a net profit margin of 33.3% over the last year. Over recent periods, the company has seen quarterly revenue move from ¥232.3 billion in Q4 FY 2025 to ¥328.1 billion in Q4 FY 2026, while quarterly basic EPS has shifted from ¥54.47 to ¥174.81. This feeds into the...

Ajinomoto (TSE:2802) has drawn investor attention after unveiling a proprietary hinokitiol based technology designed to replace transferrin in cultivated meat culture media. The company is targeting lower production costs and support for serum free, large scale applications. See our latest analysis for Ajinomoto. The cultivated meat announcement comes after a strong run in Ajinomoto’s shares, with a 30 day share price return of 5.34% and a 90 day share price return of 41.10%. The 1 year total...

Context for Shin-Etsu Chemical’s latest move Shin-Etsu Chemical (TSE:4063) has called a board meeting for April 28, 2026 to consider approving a share repurchase, coinciding with the company’s scheduled fiscal 2026 earnings release on the same day. See our latest analysis for Shin-Etsu Chemical. The share price has climbed to ¥7,064, with a 30 day share price return of 15.05% and a 1 year total shareholder return of 67.05%. This suggests momentum has been building ahead of the buyback...

Wondering if TDK is still attractively priced after a strong run, or if most of the easy gains are already on the table. TDK's share price recently closed at ¥2,681.5, with returns of 4.1% over 7 days, 27.1% over 30 days, 19.2% year to date and 86.7% over 1 year, and very large gains over 3 and 5 years of 189.0% and 197.1% respectively. Recent coverage has focused on how TDK fits into broader themes in electronics and technology hardware, with investors watching how demand trends and capital...

Hitachi (TSE:6501) has wrapped up FY 2026 with fourth quarter revenue of ¥3.1t and basic EPS of ¥36.08, set against trailing twelve month revenue of ¥10.6t and EPS of ¥176.76 that follows reported earnings growth of 30.3% over the past year. Over recent periods the company has seen quarterly revenue move from ¥2.5t and EPS of ¥30.20 in FY 2025 Q3 to ¥2.8t and EPS of ¥40.20 in FY 2025 Q4, reaching ¥3.1t and EPS of ¥36.08 in FY 2026 Q4. This positions you to focus on how a 7.6% net profit...

Astellas Pharma (TSE:4503) has laid out its FY 2026 scorecard with second half revenue of ¥1.1t and basic EPS of ¥80.33, alongside net income excluding extraordinary items of ¥143.9b. The company has seen revenue move from ¥976.7b and basic EPS of ¥12.72 in the second half of FY 2025, to ¥1.0t and ¥82.44 in the first half of FY 2026, before reaching ¥1.1t and ¥80.33 in the latest period. Over the same timeframe, trailing twelve month EPS has increased from ¥28.35 to ¥162.77. For investors,...

If you are wondering whether TOTO is priced attractively right now, the key question is how its current share price compares with its underlying worth. The stock last closed at JP¥5,421, and its returns over 1 year sit at 59.9%, with 23.6% year to date, 27.9% over 3 years, 6.6% over 5 years, 0.7% over 7 days, and a 0.1% decline over 30 days, which can change how investors think about both opportunity and risk. Recent news coverage has focused on TOTO in the context of broader market interest...

Nintendo stock performance snapshot Nintendo (TSE:7974) has been under pressure recently, with the share price showing a 0.8% decline over the past day and deeper negative returns over the past week, month, past 3 months, and year. See our latest analysis for Nintendo. With the share price at ¥7,893 and a 1 year to date share price return of 25.9% in the red, recent weakness contrasts with a 47.2% gain in the 3 year total shareholder return. If Nintendo's recent pullback has you reassessing...

Business expansion in Vietnam and what it could mean for investors Nippon Express Holdings (TSE:9147) is in focus after securing a container freight station license for its Hanoi off airport air cargo facility, a move that directly targets congestion and security concerns. See our latest analysis for Nippon Express Holdings. The logistics expansion news lands against a backdrop of solid momentum, with a 1 month share price return of 8.02% and a 1 year total shareholder return of 55.24%,...